You are here

  • Home
  • Archive
  • Volume 75, Issue 4
  • Response to: ‘Evaluation of the association between anticarbamylated protein antibodies and longitudinal course of functional ability in rheumatoid arthritis’ by Ajeganova et al

Article Text

Article menu

Download PDFPDF

Electronic pages
Correspondence response
Response to: ‘Evaluation of the association between anticarbamylated protein antibodies and longitudinal course of functional ability in rheumatoid arthritis’ by Ajeganova et al
Free
  1. J H Humphreys1,
  2. D P M Symmons1,2,
  3. S M M Verstappen1
  1. 1Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK
  2. 2NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academic Health Science Centre, Manchester, UK
  1. Correspondence to Dr Suzanne Verstappen, Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, M13 9PT, UK; suzanne.verstappen{at}manchester.ac.uk

https://doi.org/10.1136/annrheumdis-2015-208957

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Ajeganova et al1 for the interesting comments on our paper2, and note the different findings compared with our results.1 ,2 We would suggest a potential explanation for this lies within the different patient populations. Although inclusion criteria for the Swedish Better Anti-Rheumatic PharmacOTherapy (BARFOT) cohort and Leiden Early arthritis Clinic (EAC) are not detailed, we are aware from previous publications that inclusion criteria to these cohorts require patients to satisfy the 1987 American College of Rheumatology (ACR) classification criteria for rheumatoid arthritis (RA) at baseline and within 1 year of symptom onset, respectively.3 , …

    View Full Text

    Linked Articles